Delivery Order SPE2DB25D3012-SPE2DB26FWVQC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $2,551.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $5,118.70 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packaging) under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a competitive award with no set-aside designation, reflecting open competition for the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count) with a ceiling value of $1,116.90. This non-set-aside, competitively awarded contract is structured as a delivery order under a firm fixed-price arrangement, with an ultimate completion date of September 24, 2025. The award was issued on September 23, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Brilinta 90 mg tablets (60-count) valued at $2,535.30, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supply. The contract was fulfilled by AmerisourceBergen's Corporate Office division, with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) under a firm fixed-price contract valued at $4,405.19, with an ultimate completion date of August 7, 2025. This non-set-aside delivery order was competitively awarded and represents a continuation of AmerisourceBergen's pharmaceutical supply services to the federal government. The place of performance is listed as the vendor's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $32,625.18 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Brilinta is an antiplatelet medication commonly used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 mg tablets of Brilinta, a cardiovascular medication, with a ceiling value of $2,468.16. This non-set-aside, competitively awarded contract was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The firm fixed price delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Brilinta 90 mg tablets (60-count units) with a ceiling value of $1,777.25. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by August 7, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,893.27 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (100 unit dose packages) on September 15, 2025, with completion targeted for September 16, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $4,769.52. This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside contract utilizing AmerisourceBergen's existing pharmaceutical supply agreement. The order will be fulfilled from the company's corporate office location in...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB26FWVQCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) valued at $3,759.72, with an ultimate completion date of October 27, 2025. This competitively awarded, firm fixed-price delivery order was issued on October 24, 2025, with performance to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the open competition process through which it was awarded. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that supports global pharmaceutical supply to military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceuticals, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's extensive portfolio of federal contract awards demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains and order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 10/24/25 |